nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Additional Neurology Topics"

 

Antipsychotic Use in Intellectually Disabled Adults
September 1, 2017   

Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis...
 Continue reading (Members only)
Deutetrabenazine Approved to Treat Tardive Dyskinesia
August 30, 2017   

The U.S. Food and Drug Administration (FDA) has approved deutetrabenazine, trade name Austedo, for the treatment of tardive dyskinesia...
 Continue reading
What's New in Tardive Dyskinesia?
June 30, 2017   

Tardive dyskinesia was the focus of several sessions, lectures, and posters at the recent 2017 American Psychiatric Association (APA) Annual Meeting...
 Continue reading (Members only)
Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading (Members only)
First Drug Approved to Treat Tardive Dyskinesia
April 12, 2017   

The U.S. Food and Drug Administration (FDA) has approved valbenazine, trade name Ingrezza, for the treatment of tardive dyskinesia...
 Continue reading
Concussion in Children: New Data
January 11, 2017   

New studies address the association between early exercise following acute concussion and persistent postconcussive symptoms in children and adolescents as well as auditory biological markers of concussion in children.
 Continue reading (Members only)
Collaborative Care for Persistent Postconcussive Symptoms in Adolescents
December 8, 2016   

Sports-related concussions are often associated with postconcussive psychological symptoms, yet there is no evidence-based treatment for postconcussive symptoms in children and adolescents. A recent study tested a collaborative care intervention model...
 Continue reading (Members only)
Glia-Mediated Brain Inflammation after Repeated Concussions Detected In Vivo
December 1, 2016   

Microglia, the immune cells of the central nervous system, play a primary role in the brain’s response to injury and neurodegenerative processes. Single and repeated traumatic brain injuries may result in microglial activation...
 Continue reading (Members only)
Anticonvulsant-Induced Psychiatric Symptoms in Patients With Epilepsy
September 26, 2016   

As many as 30–50% of patients with epilepsy have psychiatric, behavioral, cognitive, or social problems, which in some cases may be related to the disease state, the medications, or both. Two recent publications—one a report of original research, the other a review—address this often overlooked clinical issue.
 Continue reading
FDA Alert: Medication and Medical Device Approvals
September 12, 2016   

The US FDA has approved the marketing of computerized cognitive tests to assess for possible concussions, granted tentative approval for Trokendi XR for migraine prevention, and approved abuse-deterrent Troxyca ER for severe pain management.
 Continue reading (Members only)
123
Top of Page